The Daily Feed

Enteroviruses are a large genus of viruses that include poliovirus, coxsackievirus, and echovirus. While many infections are asymptomatic, some can lead to severe diseases like paralysis, myocarditis, and hand, foot, and mouth disease (HFMD). The development of enterovirus vaccines is a major focus of public health, aimed at reducing the global burden of these often-neglected viral infections. The most famous example is the polio vaccine, which has nearly eradicated poliomyelitis worldwide.

In recent years, attention has shifted toward vaccines for Enterovirus 71 (EV71), a primary cause of severe HFMD outbreaks in the Asia-Pacific region. These outbreaks can lead to neurological complications and death in young children. Several inactivated EV71 vaccines have been developed and implemented in large-scale vaccination programs, showing high efficacy in preventing severe disease. These vaccines work by stimulating the immune system to produce neutralizing antibodies that block the virus from entering host cells.

The challenge in enterovirus vaccine development lies in the high diversity of the virus genus. A vaccine for one strain often does not provide cross-protection against others. Research is now focused on creating multivalent vaccines that can protect against several strains simultaneously. As global travel and urbanization increase the risk of rapid viral spread, the continued development and distribution of enterovirus vaccines are essential for protecting pediatric populations and preventing future epidemics.